Hersintuzumab: A novel humanized anti-HER2 monoclonal antibody induces potent tumor growth inhibition.
Amiri MM, Golsaz-Shirazi F, Soltantoyeh T, Hosseini-Ghatar R, Bahadori T, Khoshnoodi J, Navabi SS, Farid S, Karimi-Jafari MH, Jeddi-Tehrani M, Shokri F.
Amiri MM, et al. Among authors: navabi ss.
Invest New Drugs. 2018 Apr;36(2):171-186. doi: 10.1007/s10637-017-0518-0. Epub 2017 Oct 6.
Invest New Drugs. 2018.
PMID: 28983766